91.52
price up icon1.00%   0.91
pre-market  Pre-market:  91.52  
loading
Illumina Inc stock is traded at $91.52, with a volume of 2.30M. It is up +1.00% in the last 24 hours and up +13.87% over the past month. Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
See More
Previous Close:
$90.61
Open:
$91.54
24h Volume:
2.30M
Relative Volume:
1.06
Market Cap:
$13.93B
Revenue:
$4.34B
Net Income/Loss:
$-965.00M
P/E Ratio:
-15.08
EPS:
-6.07
Net Cash Flow:
$869.00M
1W Performance:
+2.29%
1M Performance:
+13.87%
6M Performance:
-32.31%
1Y Performance:
-16.98%
1-Day Range:
Value
$89.39
$91.66
1-Week Range:
Value
$88.65
$91.66
52-Week Range:
Value
$68.70
$156.66

Illumina Inc Stock (ILMN) Company Profile

Name
Name
Illumina Inc
Name
Phone
(858) 202-4500
Name
Address
5200 ILLUMINA WAY, SAN DIEGO, CA
Name
Employee
8,970
Name
Twitter
@illumina
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
ILMN's Discussions on Twitter

Compare ILMN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
ILMN
Illumina Inc
91.52 13.93B 4.34B -965.00M 869.00M -6.07
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
404.37 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
197.47 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
530.50 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
117.64 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
158.58 27.64B 15.50B 1.33B 2.16B 7.34

Illumina Inc Stock (ILMN) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-04-25 Reiterated Citigroup Neutral
Feb-28-25 Downgrade HSBC Securities Buy → Hold
Feb-10-25 Downgrade Barclays Equal Weight → Underweight
Feb-07-25 Downgrade TD Cowen Buy → Hold
Dec-11-24 Downgrade Citigroup Buy → Neutral
Nov-12-24 Resumed Morgan Stanley Equal-Weight
Oct-17-24 Upgrade HSBC Securities Hold → Buy
Aug-28-24 Upgrade Argus Hold → Buy
Aug-16-24 Upgrade Daiwa Securities Neutral → Buy
Aug-14-24 Upgrade Barclays Underweight → Equal Weight
Aug-14-24 Upgrade TD Cowen Hold → Buy
Jul-10-24 Upgrade Citigroup Neutral → Buy
Jun-03-24 Resumed Jefferies Hold
Jan-16-24 Downgrade HSBC Securities Buy → Hold
Jan-04-24 Downgrade TD Cowen Outperform → Market Perform
Dec-18-23 Upgrade Scotiabank Sector Perform → Sector Outperform
Dec-15-23 Upgrade Bernstein Underperform → Mkt Perform
Dec-14-23 Initiated Guggenheim Buy
Dec-14-23 Initiated Stephens Overweight
Dec-13-23 Initiated Wolfe Research Outperform
Dec-12-23 Downgrade BofA Securities Neutral → Underperform
Dec-11-23 Upgrade Citigroup Sell → Neutral
Nov-10-23 Downgrade Canaccord Genuity Buy → Hold
Sep-28-23 Initiated Bernstein Underperform
Jul-05-23 Resumed JP Morgan Neutral
Jan-25-23 Downgrade Argus Buy → Hold
Jan-05-23 Initiated Scotiabank Sector Perform
Dec-12-22 Downgrade Citigroup Neutral → Sell
Dec-07-22 Initiated RBC Capital Mkts Outperform
Oct-04-22 Upgrade SVB Leerink Mkt Perform → Outperform
Sep-28-22 Upgrade Evercore ISI In-line → Outperform
Aug-25-22 Initiated Credit Suisse Neutral
Jul-13-22 Downgrade Barclays Equal Weight → Underweight
Jan-18-22 Upgrade Stifel Hold → Buy
Jan-11-22 Upgrade Barclays Underweight → Equal Weight
Jan-07-22 Upgrade BofA Securities Underperform → Neutral
Jan-06-22 Resumed Morgan Stanley Equal-Weight
Jan-06-22 Resumed Piper Sandler Overweight
Oct-15-21 Resumed Cowen Outperform
Aug-19-21 Downgrade SVB Leerink Outperform → Mkt Perform
Jun-01-21 Upgrade Evercore ISI Underperform → In-line
Mar-31-21 Downgrade Atlantic Equities Overweight → Neutral
Mar-31-21 Upgrade Canaccord Genuity Hold → Buy
Mar-03-21 Initiated Barclays Underweight
Dec-22-20 Upgrade Piper Sandler Neutral → Overweight
Dec-17-20 Upgrade BTIG Research Neutral → Buy
Oct-13-20 Downgrade Guggenheim Buy → Neutral
Sep-30-20 Initiated Atlantic Equities Overweight
Sep-29-20 Downgrade Wolfe Research Outperform → Peer Perform
Sep-22-20 Downgrade Stifel Buy → Hold
Sep-22-20 Downgrade UBS Buy → Neutral
Sep-21-20 Upgrade Guggenheim Neutral → Buy
Sep-21-20 Downgrade JP Morgan Overweight → Neutral
Sep-09-20 Initiated Morgan Stanley Equal-Weight
Aug-07-20 Downgrade Evercore ISI In-line → Underperform
Aug-07-20 Downgrade Piper Sandler Overweight → Neutral
Jul-07-20 Downgrade Guggenheim Buy → Neutral
Apr-24-20 Downgrade Citigroup Buy → Neutral
Apr-21-20 Downgrade Robert W. Baird Outperform → Neutral
Jan-08-20 Initiated Wells Fargo Underweight
Jan-07-20 Initiated Citigroup Buy
Jan-02-20 Downgrade Evercore ISI Outperform → In-line
Nov-15-19 Initiated Stifel Buy
Oct-25-19 Initiated Guggenheim Buy
View All

Illumina Inc Stock (ILMN) Latest News

pulisher
Jun 18, 2025

Infinity Bio Secures $8M Series A and Acquires Serimmune to Dominate Antibody Reactome Market - Stock Titan

Jun 18, 2025
pulisher
Jun 17, 2025

DNA/Gene Microarray Market Future Trends and Scope Analysis - openPR.com

Jun 17, 2025
pulisher
Jun 17, 2025

How the DNA Data Storage Market Will Evolve by 2032Growth, - openPR.com

Jun 17, 2025
pulisher
Jun 16, 2025

Saudia Arabia Introduces Strategic Healthcare Vision and Global Partnerships at BIO 2025 - GlobeNewswire Inc.

Jun 16, 2025
pulisher
Jun 14, 2025

Next-Gen Diagnostics Drive Biochips Market Growth: Thermo Fisher, Illumina, and PerkinElmer at the Forefront - openPR.com

Jun 14, 2025
pulisher
Jun 13, 2025

Illumina and Science Centre Singapore partner for Brain Fest 2025 - Illumina

Jun 13, 2025
pulisher
Jun 12, 2025

Video: Inspiring the next generation of scientists in Singapore - Illumina

Jun 12, 2025
pulisher
Jun 12, 2025

Clinical Oncology Next Generation Sequencing Market Detailed - openPR.com

Jun 12, 2025
pulisher
Jun 11, 2025

Illumina (ILMN) Price Target Boosted by Canaccord Analyst | ILMN Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Video: Two Illumina scientists share their “why” - Illumina

Jun 11, 2025
pulisher
Jun 11, 2025

Breaking Down Illumina: 11 Analysts Share Their Views - Benzinga

Jun 11, 2025
pulisher
Jun 10, 2025

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics - Illumina

Jun 10, 2025
pulisher
Jun 10, 2025

Lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics - marketscreener.com

Jun 10, 2025
pulisher
Jun 09, 2025

Piper Sandler maintains Illumina stock Overweight, $185 target By Investing.com - Investing.com UK

Jun 09, 2025
pulisher
Jun 09, 2025

Long Read Sequencing Market Top Key Players Analysis - openPR.com

Jun 09, 2025
pulisher
Jun 07, 2025

Gemeinsam Genomik neu denken - Illumina

Jun 07, 2025
pulisher
Jun 07, 2025

Microarray Biochips Market is Booming Worldwide |Illumina,Qiagen,Eppendorf - openPR.com

Jun 07, 2025
pulisher
Jun 06, 2025

Single-cell Omics Market Projected to Witness Growth with - openPR.com

Jun 06, 2025
pulisher
Jun 06, 2025

Tumor-Derived Exosomes Market Set to Witness Significant - openPR.com

Jun 06, 2025
pulisher
Jun 06, 2025

Hereditary Testing Market Future Business Opportunities - openPR.com

Jun 06, 2025
pulisher
Jun 06, 2025

Next Generation Sequencing Market to Witness Upsurge in Growth - openPR.com

Jun 06, 2025
pulisher
Jun 05, 2025

Does Illumina (ILMN) Have Good Long-Term Growth Prospects? - Insider Monkey

Jun 05, 2025
pulisher
Jun 05, 2025

Nucleic Acid Isolation and Purification Market Size, Trends & - openPR.com

Jun 05, 2025
pulisher
Jun 04, 2025

Illumina’s DNA Test Tech Infringes Hospital Patent, Suit Claims - Bloomberg Law News

Jun 04, 2025
pulisher
Jun 04, 2025

Microbiome Sequencing Market Outlook 2025-2029 | Affordable Sequencing Instruments Expand Market Access for Smaller Labs - Yahoo

Jun 04, 2025
pulisher
Jun 04, 2025

Digital Genome Market Deep Research Report on AI-Driven DNA Analysis Trends | Illumina, Thermo Fisher Scientific - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

Forensic Genomics Market Research 2025Global Trends, Opportunity, and Forecasts 2020-2030 - GlobeNewswire Inc.

Jun 04, 2025
pulisher
Jun 03, 2025

Cancer Profiling Market Is Booming So Rapidly 2025-2032 - openPR.com

Jun 03, 2025
pulisher
Jun 03, 2025

Hereditary Testing MarketGlobal Industry Trends, Opportunity, and Forecast, 2020-2030: Key Players Like Illumina and Myriad Genetics Leading the Charge - Yahoo Finance

Jun 03, 2025
pulisher
Jun 03, 2025

Next-Gen RNA Sequencing Market | Personalized Medicine & Future - openPR.com

Jun 03, 2025
pulisher
Jun 02, 2025

Gene Panel Market Projected to Witness Massive GrowthIllumina, Inc., Thermo Fisher Scientific - openPR.com

Jun 02, 2025
pulisher
May 31, 2025

Illumina Connected Insights - Technology Networks

May 31, 2025
pulisher
May 30, 2025

Illumina Inc (ILMN) Stock Price Down 3.31% on May 30 - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Genotyping Assay Market Deep Research Report Highlights Key AdvancementsIllumina, Thermo Fisher Scientific - openPR.com

May 30, 2025
pulisher
May 30, 2025

Illumina’s PromoterAI unlocks rare disease clues in noncoding genome - statnews.com

May 30, 2025
pulisher
May 30, 2025

Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain? - Nasdaq

May 30, 2025
pulisher
May 30, 2025

Epigenetics Market Analysis 2025-2033: Advances in DNA - openPR.com

May 30, 2025
pulisher
May 30, 2025

Illumina introduces PromoterAI for rare disease diagnosis By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 30, 2025

Illumina Inc.: Tackling Global Headwinds With Strategic Market Diversification! - Smartkarma

May 30, 2025
pulisher
May 29, 2025

Illumina, Inc. (ILMN) Unveils AI Breakthrough for Rare Disease Diagnosis - Insider Monkey

May 29, 2025
pulisher
May 29, 2025

Illumina introduces PromoterAI for rare disease diagnosis - Investing.com Australia

May 29, 2025
pulisher
May 29, 2025

Operating a speedy, high-tech NGS lab in remote Australia - Illumina

May 29, 2025
pulisher
May 29, 2025

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis - Nasdaq

May 29, 2025
pulisher
May 29, 2025

Bioinformatics Market Detailed in New Research ReportThermo Fisher Scientific, Illumina - openPR.com

May 29, 2025
pulisher
May 29, 2025

DNA giant Illumina spawned an ecosystem of competitors and customers - Endpoints News

May 29, 2025
pulisher
May 29, 2025

Illumina widens access to cancer tests with Medicare and new CDx - Yahoo Finance

May 29, 2025
pulisher
May 28, 2025

Patent Fight Breaks Out over Genetic Sequencing - Orthopedics This Week

May 28, 2025
pulisher
May 28, 2025

Illumina at Bernstein Conference: Strategic Insights and Challenges - Investing.com

May 28, 2025

Illumina Inc Stock (ILMN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Illumina Inc Stock (ILMN) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Thaysen Jacob
Chief Executive Officer
May 12 '25
Buy
80.88
6,500
525,732
77,540
Thaysen Jacob
Chief Executive Officer
May 13 '25
Buy
80.84
5,850
472,942
83,390
diagnostics_research DGX
$179.90
price up icon 0.10%
diagnostics_research WAT
$346.80
price up icon 1.16%
diagnostics_research LH
$262.53
price up icon 0.57%
$171.87
price up icon 0.88%
diagnostics_research MTD
$1,185.18
price up icon 1.85%
diagnostics_research IQV
$158.58
price up icon 2.20%
Cap:     |  Volume (24h):